Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6132
|
pubmed:dateCreated |
1987-9-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-0836
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
328
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
660
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3302728-Bacterial Vaccines,
pubmed-meshheading:3302728-Clinical Trials as Topic,
pubmed-meshheading:3302728-Cross Reactions,
pubmed-meshheading:3302728-Humans,
pubmed-meshheading:3302728-India,
pubmed-meshheading:3302728-Lepromin,
pubmed-meshheading:3302728-Leprosy,
pubmed-meshheading:3302728-Mycobacterium avium,
pubmed-meshheading:3302728-Mycobacterium leprae
|
pubmed:articleTitle |
India carries out large-scale tests of anti-leprosy vaccine.
|
pubmed:publicationType |
Clinical Trial,
News
|